DS-TO-THE-MAX Grant Year 2
This newsletter provides an overview of the discoveries, publications, and activities supported by Year 2 funding under the DS-TO-THE-MAX grant.
Read the full article here:
The Rubenstein Lab. Down syndrome towards optimal trajectories and health equity using Medicaid Analytic eXtract (DS-TO-THE-MAX) Grant Year 2: 2022-2023.